US Vaccine Market Size, Growth, Opportunity, Forecast and Covid-19 Impact Analysis to 2025

Brandessece Market Research recently added the Vaccine Market research report which offers a thorough study of the market scenario regarding the market size, share, demand, growth,  trends, and forecast from 2020-2026. The report deals with the impact analysis of the COVID-19 pandemic. The COVID-19 pandemic has impacted exports, imports, demand and trends in the industry and is expected to have some economic impact on the market. The report offers a comprehensive analysis of the impact of the pandemic across the industry and provides insights into a post-COVID-19 market scenario.

Scope of US Vaccine Market Reports –

A vaccine is a biological preparationwhich is administered to produceactive acquired immunity for particular disease and it is prepared from weakened or killed forms of the microorganism such as bacteria & viruses or from its toxins or proteins. Administration of vaccines is called as “Vaccination” which aids to increase the immune response against a specific pathogen.Human body has natural ability to learn about eliminating all sorts of germs or microbes that cause diseases. Vaccine uses that ability of the body to enable it to defend itself from those microorganisms which have attacked it earlier. Usually vaccines are administered through injections, orally and sprayed into the nose.Vaccines can be divides into many types such as inactivated vaccines, attenuated vaccines, toxoid, and conjugate. Cholera, influenza, hepatitis A, polio, and rabies vaccines are inactivated vaccines.

Get Sample of This Report@

*The sample pages of this report is immediately accessible on-demand.**

The US Vaccines Market is categorized on the basis of the various diseases that can either be prevented or treated by using vaccines. Various diseases that are treated using H1N1 vaccines include influenza, meningococcal, cervical cancer, pneumococcal, hepatitis, measles, mumps, rubella, etc.The demand for vaccinations has increased over the last few years, due to the rising incidence of viral and bacterial infectious diseases. Vaccinations are essentially administered to people of different age groups, which build up their immune system throughout lifespan and gives protection against different types of infectious diseases.Vaccine technology is procedure to observe a revolution. As a more understanding of the human immune system’s protective antibody and cell-based responses to foreign antigens will causes the development of advanced diagnostics and improvement of therapeutic applications. As further governments across the

World identify the welfare of mass vaccination, the trend of vaccines providing healthcare solutions on a large scale will continue. Certain increasing demand worldwide and currently-unmet needs, the US Vaccination Market has substantial potential for technological novelty and revenue growth.Vaccines are a supreme tool for effective healthcare management due to their low cost and prolonged protection. The increasing popularity of pediatric, travel, addiction and pediatric combination vaccines the newly developed vaccines that are safer and more effective, better public awareness, technological advancements in molecular genetics area and the adoption of novel vaccine delivery mechanisms are chiefly driving the growth of the US vaccination market. Moreover, the production of new therapeutic and prophylactic vaccines for fighting HIV/AIDS, congenital abnormalities, malaria and cancer, as well as other deadly diseases is also boost the US Vaccine Market growth.

Immunization presently prevents an estimated 2 to 3 million deaths per year. Moreover additional 1.5 million deaths could be avoided due to enhanced US vaccination coverage. Increasing acceptance of new and underused vaccines will highly strengthen its US usage in the upcoming future.

US Vaccines Market has been segmented on the basis of Technology, Indication, End User and Geography. On the basis of TechnologyUS Vaccines Market is classified into Conjugate Vaccines, Live Attenuated Vaccines,Inactivated Vaccines Toxoid Vaccines, Recombinant Vaccines and Others. On the basis of IndicationUS Vaccines Market is segmented into Influenza, Pneumococcal Disease, Meningococcal Disease, Human Papilloma Virus, Rotavirus, Varicella, Diphtheria-Pertussis-Tetanus (DTP), Polio, Hepatitis, Measles-Mumps- Rubella (MMR) and others. On the basis of End User US Vaccines Market is classified into Pediatric Vaccines, Adult Vaccines, Traveler Vaccines and Others.

The regions covered in US Vaccines Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, US Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Vaccines Companies:

US Vaccines Market reports cover prominent players like Glaxo Smith Kline plc, Pfizer Inc., Merck & Co. Inc., Sanofi, CSL Limited, Emergent BioSolutions Inc. , Johnson & Johnson, Medimmune, LLC, AstellasPharma Inc., Serum Institute of India, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Bavarian Nordic,Panacea Biotech, Protein Sciences Corporation, AstraZeneca, Abbott, Bristol-Myers Squibb,Novavax Inc., Gritstone Oncology, PaxVax Corporation.,Bharat Biotech., VBI Vaccines Inc.,Dynavax Technologies Corporation, Immunomic Therapeutics, Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Prokarium, and ImmunoBiology Ltd.,Janssen Pharmaceutical Company,Takeda Pharmaceuticals Company Ltd., Valeant Pharmaceuticals International, Inc., China National Biotech, Tiantan, Hualan, Kangtai,Hissen andJintan.

US Vaccines Market Dynamics –

The rise in acceptance of pediatrics, travel, addiction, and pediatric combination vaccines also recently developed vaccines that are safer and more effective, better, public awareness, technological advancements in molecular genetics area and the acceptance of new vaccine delivery mechanisms are mainly driving the growth of the US Vaccination Market. Rise inincidence of infectious diseases such as influenza, malaria, pneumonia, measles, meningococcal meningitis, dengue, HIV, hepatitis, and diphtheria is somewhat high, as well asGovernment initiatives for expanding vaccination coverage are likely to boost the demand for vaccines USly. The Government of Asian country launched the ‘Pan-India campaign for contagious disease-Rubella Vaccination’ in February 2017 to safeguard kids from chief childhood diseases like three-day measles and Measles.This nationwide vaccination campaign aims to administer measles-rubella vaccine (MR-VAC) to children aged between nine months and 15 years and increasing investments by companies are driving the vaccine market.Excessive cost related with storage and transportation of vaccines will restrain the US Vaccine Market growth. Limited reimbursement coverage and stringent government regulations for the approval of products will further hamper the US Vaccine Market expansion over the coming years. Crucial problems in the US Vaccine Market now a days are product safety, supply shortages, use of vaccines to prevent infectious diseases and discoveries in vaccine delivery systems.

Market Segmentation:

By Technology

  • Conjugate Vaccines
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Others

By Indication

  • Influenza
  • Pneumococcal Disease
  • Meningococcal Disease
  • Human Papilloma Virus
  • Rotavirus
  • Varicella
  • Diphtheria-Pertussis-Tetanus (DTP)
  • Polio
  • Hepatitis
  • Measles-Mumps- Rubella (MMR)
  • Others

By End User

  • Pediatric Vaccines
  • Adult Vaccines
  • Traveller Vaccines
  • Others

Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa

Table of Content

1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description

2. Chapter – US Vaccine Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. US Vaccine Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Vaccine Market: Trends
2.8. Porter’s Five Forces Analysis
2.9. Market Attractiveness Analysis

3. Chapter – US Vaccine Market Overview: Quantitative Analysis

4. Chapter – US Vaccine Market Analysis: Segmentation By Type

5. Chapter – US Vaccine Market Analysis: Segmentation By Application


Full Research Report @

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at